Clinical Trial Update: Dose-dense Biweekly Docetaxel, Oxaliplatin and 5-fluorouracil as First-line Treatment in Advanced Gastric Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating a dose-dense biweekly combination of docetaxel, oxaliplatin, and 5-fluorouracil as first-line treatment for advanced gastric c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• Adrucil (5-fluorouracil)
• Eloxatin (oxaliplatin)
• Taxotere (docetaxel)

Snippet

Sponsor: Sixth Affiliated Hospital, Sun Yat-sen University | Conditions: Docetaxel, Oxaliplatin and Fluorouracil | Phase 2 | Status: UNKNOWN